ROYAL BANK OF CANADA - FLEXION THERAPEUTICS INC ownership

FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 122 filers reported holding FLEXION THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of FLEXION THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$1,203,000
-24.1%
197,167
+2.4%
0.00%
Q2 2021$1,584,000
-3.5%
192,464
+4.9%
0.00%
Q1 2021$1,642,000
-27.3%
183,501
-6.3%
0.00%
-100.0%
Q4 2020$2,260,000
-14.4%
195,877
-22.8%
0.00%0.0%
Q3 2020$2,640,000
-23.1%
253,633
-2.9%
0.00%0.0%
Q2 2020$3,434,000
+34.4%
261,183
-19.6%
0.00%0.0%
Q1 2020$2,555,000
-65.9%
324,659
-10.4%
0.00%
-66.7%
Q4 2019$7,498,000
+44.6%
362,196
-4.3%
0.00%
+50.0%
Q3 2019$5,187,000
+18.1%
378,478
+6.0%
0.00%0.0%
Q2 2019$4,391,000
-2.1%
356,967
-0.7%
0.00%0.0%
Q1 2019$4,484,000
+12.9%
359,311
+2.4%
0.00%0.0%
Q4 2018$3,972,000
-62.2%
350,870
-37.5%
0.00%
-50.0%
Q3 2018$10,504,000
-26.0%
561,416
+2.2%
0.00%
-33.3%
Q2 2018$14,199,000
+11.3%
549,302
-3.5%
0.01%0.0%
Q1 2018$12,760,000
-10.4%
569,401
+0.1%
0.01%0.0%
Q4 2017$14,248,000
+29.1%
568,985
+24.7%
0.01%
+20.0%
Q3 2017$11,035,000
+41.9%
456,384
+18.7%
0.01%
+25.0%
Q2 2017$7,776,000
-6.6%
384,565
+24.3%
0.00%0.0%
Q1 2017$8,327,000
+65.2%
309,417
+16.7%
0.00%
+33.3%
Q4 2016$5,041,000
+125.2%
265,055
+131.4%
0.00%
+200.0%
Q3 2016$2,238,000
+119.6%
114,548
+68.3%
0.00%0.0%
Q2 2016$1,019,000
+283.1%
68,058
+135.6%
0.00%
Q1 2016$266,000
-49.5%
28,893
+5.7%
0.00%
Q4 2015$527,000
+2.9%
27,327
-20.7%
0.00%
Q3 2015$512,000
+848.1%
34,444
+1296.8%
0.00%
Q2 2015$54,000
+134.8%
2,466
+146.6%
0.00%
Q1 2015$23,0001,0000.00%
Other shareholders

There were no reported owners of FLEXION THERAPEUTICS INC in Q3 2017.

NameSharesValueWeighting ↓
View complete list of FLEXION THERAPEUTICS INC shareholders